プロテオミクスのグローバル市場2023~2027:試薬、器械、サービス

【英語タイトル】Global Proteomics Market 2023-2027

Technavioが出版した調査資料(IRTNTR46436-23)・商品コード:IRTNTR46436-23
・発行会社(調査会社):Technavio
・発行日:2023年5月3日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア太平洋、アメリカ、イギリス、ドイツ、中国、日本、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本市場調査レポートでは、世界のプロテオミクス市場規模が2022年から2027年の間に21,749.32百万ドルまで到達し、予測期間中に年平均13.05%成長すると見込まれます。本レポートではプロテオミクスの世界市場について多角的に調査・分析し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、製品別(試薬、器械、サービス)分析、エンドユーザー別(臨床診断、創薬、その他)分析、地域別状況(北米、ヨーロッパ、アジア太平洋、アメリカ、イギリス、ドイツ、中国、日本、その他)分析、成長要因・課題・動向、企業状況、企業分析などの内容を掲載しています。なお、参入企業情報としてAgilent Technologies Inc.、Applied Biomics Inc.、Bio Rad Laboratories Inc.、Biognosys AG、Bruker Corp.、CellCarta Biosciences Inc.、Creative Proteomics、DiaSorin Spa、F. Hoffmann La Roche Ltd.、Geno Technology Inc.、HORIBA Ltd.、Merck KGaAなどが含まれています。
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界のプロテオミクス市場規模:製品別
- 試薬の市場規模
- 器械の市場規模
- サービスの市場規模
・世界のプロテオミクス市場規模:エンドユーザー別
- 臨床診断における市場規模
- 創薬における市場規模
- その他エンドユーザーにおける市場規模
・地域別状況
- 北米のプロテオミクス市場規模
- ヨーロッパのプロテオミクス市場規模
- アジア太平洋のプロテオミクス市場規模
- 南米のプロテオミクス市場規模
- 中東・アフリカのプロテオミクス市場規模
- アメリカのプロテオミクス市場規模
- イギリスのプロテオミクス市場規模
- ドイツのプロテオミクス市場規模
- 中国のプロテオミクス市場規模
- 日本のプロテオミクス市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要な変数を分析することで、また、複数のソースからのデータを調査・統合・合計することにより、プロテオミクス市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することで、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確なプロテオミクス市場の成長を予測するための定性的・定量的調査を用い、徹底的な競合状況と詳細に及ぶベンダー選定・分析を提供します。

プロテオミクスの世界市場 2023-2027

プロテオミクス市場は2022-2027年に21,749.32百万米ドルの成長が予測され、予測期間中のCAGRは13.05%で加速すると予測されています。この調査レポートは、プロテオミクス市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。プロテオミクス研究の進展、精密プロテオミクスの出現、プロテオミクスの自動化の進展などが市場を牽引しています。

Technavioのプロテオミクス市場は以下のように区分されています:

・製品別:
- 試薬
- 機器
- サービス

・エンドユーザー別:
- 臨床診断
- 創薬
- その他

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間のプロテオミクス市場の成長を牽引する主な要因の一つとして、PTMのモニタリングへの注目が高まっていることを挙げています。また、ラベルフリーの定量化技術の出現と個別化医療に対する需要の増加は、市場の大きな需要につながるでしょう。

当レポートでは、プロテオミクス市場について以下の分野をカバーしています:
- プロテオミクス市場のサイジング
- プロテオミクス市場の予測
- プロテオミクス市場の産業分析

強固なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Agilent Technologies Inc., Applied Biomics Inc., Bio Rad Laboratories Inc., Biognosys AG, Bruker Corp., CellCarta Biosciences Inc., Creative Proteomics, DiaSorin Spa, F. Hoffmann La Roche Ltd., Geno Technology Inc., HORIBA Ltd., Merck KGaA, Olink Holding AB, Perkin Elmer Inc., Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., Waters Corp., Cell Signaling Technology Inc., and Illumina Inc.などの企業情報が含まれています。また、プロテオミクス市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープを掲載しています。

当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約することで、市場の詳細な姿を提示しています。業界の主要な影響者を特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global proteomics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global proteomics market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Reagents – Market size and forecast 2022-2027
o Exhibit 34: Chart on Reagents – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Reagents – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Reagents – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Reagents – Year-over-year growth 2022-2027 (%)
o 6.4 Instruments – Market size and forecast 2022-2027
o Exhibit 38: Chart on Instruments – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Instruments – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Instruments – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Instruments – Year-over-year growth 2022-2027 (%)
o 6.5 Services – Market size and forecast 2022-2027
o Exhibit 42: Chart on Services – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Services – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Services – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Services – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Product
o Exhibit 46: Market opportunity by Product ($ million)
o Exhibit 47: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 48: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 49: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 50: Chart on Comparison by End-user
o Exhibit 51: Data Table on Comparison by End-user
o 7.3 Clinical diagnostics – Market size and forecast 2022-2027
o Exhibit 52: Chart on Clinical diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Clinical diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Clinical diagnostics – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Clinical diagnostics – Year-over-year growth 2022-2027 (%)
o 7.4 Drug discovery – Market size and forecast 2022-2027
o Exhibit 56: Chart on Drug discovery – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Drug discovery – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Drug discovery – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Drug discovery – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 60: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 64: Market opportunity by End-user ($ million)
o Exhibit 65: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 103: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 115: Agilent Technologies Inc. – Overview
o Exhibit 116: Agilent Technologies Inc. – Business segments
o Exhibit 117: Agilent Technologies Inc. – Key offerings
o Exhibit 118: Agilent Technologies Inc. – Segment focus
o 12.4 Bio Rad Laboratories Inc.
o Exhibit 119: Bio Rad Laboratories Inc. – Overview
o Exhibit 120: Bio Rad Laboratories Inc. – Business segments
o Exhibit 121: Bio Rad Laboratories Inc. – Key news
o Exhibit 122: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 123: Bio Rad Laboratories Inc. – Segment focus
o 12.5 Bruker Corp.
o Exhibit 124: Bruker Corp. – Overview
o Exhibit 125: Bruker Corp. – Business segments
o Exhibit 126: Bruker Corp. – Key news
o Exhibit 127: Bruker Corp. – Key offerings
o Exhibit 128: Bruker Corp. – Segment focus
o 12.6 CellCarta Biosciences Inc.
o Exhibit 129: CellCarta Biosciences Inc. – Overview
o Exhibit 130: CellCarta Biosciences Inc. – Product / Service
o Exhibit 131: CellCarta Biosciences Inc. – Key offerings
o 12.7 Creative Proteomics
o Exhibit 132: Creative Proteomics – Overview
o Exhibit 133: Creative Proteomics – Product / Service
o Exhibit 134: Creative Proteomics – Key offerings
o 12.8 DiaSorin Spa
o Exhibit 135: DiaSorin Spa – Overview
o Exhibit 136: DiaSorin Spa – Business segments
o Exhibit 137: DiaSorin Spa – Key offerings
o Exhibit 138: DiaSorin Spa – Segment focus
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 139: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 140: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 141: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 142: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 143: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 HORIBA Ltd.
o Exhibit 144: HORIBA Ltd. – Overview
o Exhibit 145: HORIBA Ltd. – Business segments
o Exhibit 146: HORIBA Ltd. – Key news
o Exhibit 147: HORIBA Ltd. – Key offerings
o Exhibit 148: HORIBA Ltd. – Segment focus
o 12.11 Illumina Inc.
o Exhibit 149: Illumina Inc. – Overview
o Exhibit 150: Illumina Inc. – Business segments
o Exhibit 151: Illumina Inc. – Key news
o Exhibit 152: Illumina Inc. – Key offerings
o Exhibit 153: Illumina Inc. – Segment focus
o 12.12 Merck KGaA
o Exhibit 154: Merck KGaA – Overview
o Exhibit 155: Merck KGaA – Business segments
o Exhibit 156: Merck KGaA – Key news
o Exhibit 157: Merck KGaA – Key offerings
o Exhibit 158: Merck KGaA – Segment focus
o 12.13 Perkin Elmer Inc.
o Exhibit 159: Perkin Elmer Inc. – Overview
o Exhibit 160: Perkin Elmer Inc. – Business segments
o Exhibit 161: Perkin Elmer Inc. – Key news
o Exhibit 162: Perkin Elmer Inc. – Key offerings
o Exhibit 163: Perkin Elmer Inc. – Segment focus
o 12.14 Promega Corp.
o Exhibit 164: Promega Corp. – Overview
o Exhibit 165: Promega Corp. – Product / Service
o Exhibit 166: Promega Corp. – Key offerings
o 12.15 QIAGEN NV
o Exhibit 167: QIAGEN NV – Overview
o Exhibit 168: QIAGEN NV – Product / Service
o Exhibit 169: QIAGEN NV – Key news
o Exhibit 170: QIAGEN NV – Key offerings
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 171: Thermo Fisher Scientific Inc. – Overview
o Exhibit 172: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 173: Thermo Fisher Scientific Inc. – Key news
o Exhibit 174: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 175: Thermo Fisher Scientific Inc. – Segment focus
o 12.17 Waters Corp.
o Exhibit 176: Waters Corp. – Overview
o Exhibit 177: Waters Corp. – Business segments
o Exhibit 178: Waters Corp. – Key news
o Exhibit 179: Waters Corp. – Key offerings
o Exhibit 180: Waters Corp. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 181: Inclusions checklist
o Exhibit 182: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 183: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 184: Research methodology
o Exhibit 185: Validation techniques employed for market sizing
o Exhibit 186: Information sources
o 13.5 List of abbreviations
o Exhibit 187: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global proteomics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Reagents – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Reagents – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Reagents – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Reagents – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Instruments – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Instruments – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Instruments – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Instruments – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Services – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Services – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Services – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Services – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Product ($ million)
Exhibits47: Data Table on Market opportunity by Product ($ million)
Exhibits48: Chart on End-user – Market share 2022-2027 (%)
Exhibits49: Data Table on End-user – Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by End-user
Exhibits51: Data Table on Comparison by End-user
Exhibits52: Chart on Clinical diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Clinical diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Clinical diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Clinical diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Drug discovery – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Drug discovery – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Drug discovery – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Drug discovery – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Agilent Technologies Inc. – Overview
Exhibits116: Agilent Technologies Inc. – Business segments
Exhibits117: Agilent Technologies Inc. – Key offerings
Exhibits118: Agilent Technologies Inc. – Segment focus
Exhibits119: Bio Rad Laboratories Inc. – Overview
Exhibits120: Bio Rad Laboratories Inc. – Business segments
Exhibits121: Bio Rad Laboratories Inc. – Key news
Exhibits122: Bio Rad Laboratories Inc. – Key offerings
Exhibits123: Bio Rad Laboratories Inc. – Segment focus
Exhibits124: Bruker Corp. – Overview
Exhibits125: Bruker Corp. – Business segments
Exhibits126: Bruker Corp. – Key news
Exhibits127: Bruker Corp. – Key offerings
Exhibits128: Bruker Corp. – Segment focus
Exhibits129: CellCarta Biosciences Inc. – Overview
Exhibits130: CellCarta Biosciences Inc. – Product / Service
Exhibits131: CellCarta Biosciences Inc. – Key offerings
Exhibits132: Creative Proteomics – Overview
Exhibits133: Creative Proteomics – Product / Service
Exhibits134: Creative Proteomics – Key offerings
Exhibits135: DiaSorin Spa – Overview
Exhibits136: DiaSorin Spa – Business segments
Exhibits137: DiaSorin Spa – Key offerings
Exhibits138: DiaSorin Spa – Segment focus
Exhibits139: F. Hoffmann La Roche Ltd. – Overview
Exhibits140: F. Hoffmann La Roche Ltd. – Business segments
Exhibits141: F. Hoffmann La Roche Ltd. – Key news
Exhibits142: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits143: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits144: HORIBA Ltd. – Overview
Exhibits145: HORIBA Ltd. – Business segments
Exhibits146: HORIBA Ltd. – Key news
Exhibits147: HORIBA Ltd. – Key offerings
Exhibits148: HORIBA Ltd. – Segment focus
Exhibits149: Illumina Inc. – Overview
Exhibits150: Illumina Inc. – Business segments
Exhibits151: Illumina Inc. – Key news
Exhibits152: Illumina Inc. – Key offerings
Exhibits153: Illumina Inc. – Segment focus
Exhibits154: Merck KGaA – Overview
Exhibits155: Merck KGaA – Business segments
Exhibits156: Merck KGaA – Key news
Exhibits157: Merck KGaA – Key offerings
Exhibits158: Merck KGaA – Segment focus
Exhibits159: Perkin Elmer Inc. – Overview
Exhibits160: Perkin Elmer Inc. – Business segments
Exhibits161: Perkin Elmer Inc. – Key news
Exhibits162: Perkin Elmer Inc. – Key offerings
Exhibits163: Perkin Elmer Inc. – Segment focus
Exhibits164: Promega Corp. – Overview
Exhibits165: Promega Corp. – Product / Service
Exhibits166: Promega Corp. – Key offerings
Exhibits167: QIAGEN NV – Overview
Exhibits168: QIAGEN NV – Product / Service
Exhibits169: QIAGEN NV – Key news
Exhibits170: QIAGEN NV – Key offerings
Exhibits171: Thermo Fisher Scientific Inc. – Overview
Exhibits172: Thermo Fisher Scientific Inc. – Business segments
Exhibits173: Thermo Fisher Scientific Inc. – Key news
Exhibits174: Thermo Fisher Scientific Inc. – Key offerings
Exhibits175: Thermo Fisher Scientific Inc. – Segment focus
Exhibits176: Waters Corp. – Overview
Exhibits177: Waters Corp. – Business segments
Exhibits178: Waters Corp. – Key news
Exhibits179: Waters Corp. – Key offerings
Exhibits180: Waters Corp. – Segment focus
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations



★調査レポート[プロテオミクスのグローバル市場2023~2027:試薬、器械、サービス] (コード:IRTNTR46436-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[プロテオミクスのグローバル市場2023~2027:試薬、器械、サービス]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆